Press release
Creative Biolabs: Catch Them at AET 2024 With Their Recombinant Antibodies
Creative Biolabs attends the influential AET conference at Booth #620 for intensive discussions about innovative solutions in antibody therapeutics.
New York, USA - December 17, 2024 - "We're excited to be back at AET US 2024, ready for some stimulating conversations about the latest innovations in antibody therapeutics. It's going to be an amazing opportunity, as always, to connect with researchers and industry experts who are pushing the boundaries of recombinant antibody [https://www.creativebiolabs.net/hi-affi-tm-recombinant-antibodies.htm] development." A delegate from Creative Biolabs says.
Image: https://www.getnews.info/uploads/0c59d26f78bf6dd58aafee5bc68d7d8c.jpg
Recent headlines underscore the booming interest in antibody-based therapies, with recombinant antibodies, biosimilars, and scalable production methods taking center stage. Known for accelerating the development of next-generation antibodies, this prestigious event dives into critical topics like mAbs, bsAbs, ADCs, and oncology-relevant topics like neurodegenerative diseases and tumor microenvironments as well.
Creative Biolabs continues to set the bar in antibody research and development, providing a suite of services designed to meet the most demanding project requirements. Among their standout offerings are:
Recombinant Antibodies
Powered by a proprietary Hi-Affi Trademark technology, Creative Biolabs delivers recombinant antibodies with unmatched purity (over 98%), affinity, and outstanding reproducibility, which, as versatile as they can be, support extensive applications, from diagnostic tools to therapeutic outreach.
* Human/humanized antibodies, chimeric antibodies, sdAbs, model organism antibodies, etc.
High-Throughput Antibody Production [https://www.creativebiolabs.net/high-throughput-antibody-production.htm]
Addressing the growing need for affordable therapeutic options, Creative Biolabs launches AI-driven high-throughput antibody development & production, which optimizes the antibody screening process to efficiently display multiple antibody variants by phage display systems and integrates single B cell technology for antibody analysis, mutually contributing to the efficient identification and validation of promising antibody candidates with satisfactory binding capabilities.
* Single B Cell Antibody Discovery
* Phage Display-Mediated Antibody Discovery
Non-GMP Antibody Production Pipeline [https://www.creativebiolabs.net/non-gmp-antibody-production.htm]
For early-stage research, Creative Biolabs offers non-GMP antibody production-transitioning monoclonal antibodies through the whole product life cycle from concept in early stage development to large-scale non-GMP commercialization, which are tailored for pilot studies and preclinical testing.
* Prokaryotic Antibody
* Eukaryotic Antibody
The Creative Biolabs team will be in position onsite at the AET 2024 event, ready to discuss their varied, customized antibody discovery solutions. Participants can simply express their project needs and explore what Creative Biolabs can do to help bring their ideas to fruition.
"If you're here at AET, welcome to swing by booth 620 and talk to our team," the delegate says. "Whether you're looking for customized solutions for antibody discovery or a reliable supplier of high-quality research-use reagents, we're here to help make all your visions a reality."
Website: https://www.creativebiolabs.net
About
Creative Biolabs dedicates itself to all top-tier solutions to support antibody R&D from start to finish, focusing on delivering quality, speed, and flexibility to meet the unique needs of every project.
Their event arrangement for 2025 includes:
* Scientist Solution Vendor Event - Johns Hopkins - March 13, 2025
* 16th Annual World Bispecific Summit - September, 2025
* 7th Exosome-Based Therapeutic Development Summit - October, 2025
* 16th Annual World ADC San Diego - November, 2025
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email [http://www.universalpressrelease.com/?pr=creative-biolabs-catch-them-at-aet-2024-with-their-recombinant-antibodies]
Phone: 1-631-830-6441
Country: United States
Website: https://www.creativebiolabs.net
New York, USA - December 17, 2024 - "We're excited to be back at AET US 2024, ready for some stimulating conversations about the latest innovations in antibody therapeutics. It's going to be an amazing opportunity, as always, to connect with researchers and industry experts who are pushing the boundaries of recombinant antibody [https://www.creativebiolabs.net/hi-affi-tm-recombinant-antibodies.htm] development." A delegate from Creative Biolabs says.
Image: https://www.getnews.info/uploads/0c59d26f78bf6dd58aafee5bc68d7d8c.jpg
Recent headlines underscore the booming interest in antibody-based therapies, with recombinant antibodies, biosimilars, and scalable production methods taking center stage. Known for accelerating the development of next-generation antibodies, this prestigious event dives into critical topics like mAbs, bsAbs, ADCs, and oncology-relevant topics like neurodegenerative diseases and tumor microenvironments as well.
Creative Biolabs continues to set the bar in antibody research and development, providing a suite of services designed to meet the most demanding project requirements. Among their standout offerings are:
Recombinant Antibodies
Powered by a proprietary Hi-Affi Trademark technology, Creative Biolabs delivers recombinant antibodies with unmatched purity (over 98%), affinity, and outstanding reproducibility, which, as versatile as they can be, support extensive applications, from diagnostic tools to therapeutic outreach.
* Human/humanized antibodies, chimeric antibodies, sdAbs, model organism antibodies, etc.
High-Throughput Antibody Production [https://www.creativebiolabs.net/high-throughput-antibody-production.htm]
Addressing the growing need for affordable therapeutic options, Creative Biolabs launches AI-driven high-throughput antibody development & production, which optimizes the antibody screening process to efficiently display multiple antibody variants by phage display systems and integrates single B cell technology for antibody analysis, mutually contributing to the efficient identification and validation of promising antibody candidates with satisfactory binding capabilities.
* Single B Cell Antibody Discovery
* Phage Display-Mediated Antibody Discovery
Non-GMP Antibody Production Pipeline [https://www.creativebiolabs.net/non-gmp-antibody-production.htm]
For early-stage research, Creative Biolabs offers non-GMP antibody production-transitioning monoclonal antibodies through the whole product life cycle from concept in early stage development to large-scale non-GMP commercialization, which are tailored for pilot studies and preclinical testing.
* Prokaryotic Antibody
* Eukaryotic Antibody
The Creative Biolabs team will be in position onsite at the AET 2024 event, ready to discuss their varied, customized antibody discovery solutions. Participants can simply express their project needs and explore what Creative Biolabs can do to help bring their ideas to fruition.
"If you're here at AET, welcome to swing by booth 620 and talk to our team," the delegate says. "Whether you're looking for customized solutions for antibody discovery or a reliable supplier of high-quality research-use reagents, we're here to help make all your visions a reality."
Website: https://www.creativebiolabs.net
About
Creative Biolabs dedicates itself to all top-tier solutions to support antibody R&D from start to finish, focusing on delivering quality, speed, and flexibility to meet the unique needs of every project.
Their event arrangement for 2025 includes:
* Scientist Solution Vendor Event - Johns Hopkins - March 13, 2025
* 16th Annual World Bispecific Summit - September, 2025
* 7th Exosome-Based Therapeutic Development Summit - October, 2025
* 16th Annual World ADC San Diego - November, 2025
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email [http://www.universalpressrelease.com/?pr=creative-biolabs-catch-them-at-aet-2024-with-their-recombinant-antibodies]
Phone: 1-631-830-6441
Country: United States
Website: https://www.creativebiolabs.net
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
